213 related articles for article (PubMed ID: 28887153)
1. The Eya phosphatase: Its unique role in cancer.
Zhou H; Zhang L; Vartuli RL; Ford HL; Zhao R
Int J Biochem Cell Biol; 2018 Mar; 96():165-170. PubMed ID: 28887153
[TBL] [Abstract][Full Text] [Related]
2. Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression.
Zhang L; Zhou H; Li X; Vartuli RL; Rowse M; Xing Y; Rudra P; Ghosh D; Zhao R; Ford HL
Nat Commun; 2018 Mar; 9(1):1047. PubMed ID: 29535359
[TBL] [Abstract][Full Text] [Related]
3. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.
Hughes CJ; Alderman C; Wolin AR; Fields KM; Zhao R; Ford HL
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189098. PubMed ID: 38555001
[TBL] [Abstract][Full Text] [Related]
4. The multi-functional eyes absent proteins.
Hegde RS; Roychoudhury K; Pandey RN
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):372-385. PubMed ID: 32727223
[TBL] [Abstract][Full Text] [Related]
5. The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.
Tadjuidje E; Wang TS; Pandey RN; Sumanas S; Lang RA; Hegde RS
PLoS One; 2012; 7(4):e34806. PubMed ID: 22545090
[TBL] [Abstract][Full Text] [Related]
6. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis.
Li X; Oghi KA; Zhang J; Krones A; Bush KT; Glass CK; Nigam SK; Aggarwal AK; Maas R; Rose DW; Rosenfeld MG
Nature; 2003 Nov; 426(6964):247-54. PubMed ID: 14628042
[TBL] [Abstract][Full Text] [Related]
7. The Eyes Absent phosphatase-transactivator proteins promote proliferation, transformation, migration, and invasion of tumor cells.
Pandey RN; Rani R; Yeo EJ; Spencer M; Hu S; Lang RA; Hegde RS
Oncogene; 2010 Jun; 29(25):3715-22. PubMed ID: 20418914
[TBL] [Abstract][Full Text] [Related]
8. Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation.
Vartuli RL; Zhou H; Zhang L; Powers RK; Klarquist J; Rudra P; Vincent MY; Ghosh D; Costello JC; Kedl RM; Slansky JE; Zhao R; Ford HL
J Clin Invest; 2018 Jun; 128(6):2535-2550. PubMed ID: 29757193
[TBL] [Abstract][Full Text] [Related]
9. The SIX1-EYA transcriptional complex as a therapeutic target in cancer.
Blevins MA; Towers CG; Patrick AN; Zhao R; Ford HL
Expert Opin Ther Targets; 2015 Feb; 19(2):213-25. PubMed ID: 25555392
[TBL] [Abstract][Full Text] [Related]
10. The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.
Wang Y; Tadjuidje E; Pandey RN; Stefater JA; Smith LE; Lang RA; Hegde RS
Am J Pathol; 2016 Mar; 186(3):568-78. PubMed ID: 26765957
[TBL] [Abstract][Full Text] [Related]
11. The Eyes Absent proteins in development and disease.
Tadjuidje E; Hegde RS
Cell Mol Life Sci; 2013 Jun; 70(11):1897-913. PubMed ID: 22971774
[TBL] [Abstract][Full Text] [Related]
12. WDR1 is a novel EYA3 substrate and its dephosphorylation induces modifications of the cellular actin cytoskeleton.
Mentel M; Ionescu AE; Puscalau-Girtu I; Helm MS; Badea RA; Rizzoli SO; Szedlacsek SE
Sci Rep; 2018 Feb; 8(1):2910. PubMed ID: 29440662
[TBL] [Abstract][Full Text] [Related]
13. Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity.
Krueger AB; Dehdashti SJ; Southall N; Marugan JJ; Ferrer M; Li X; Ford HL; Zheng W; Zhao R
J Biomol Screen; 2013 Jan; 18(1):85-96. PubMed ID: 22820394
[TBL] [Abstract][Full Text] [Related]
14. Dephosphorylation of the C-terminal tyrosyl residue of the DNA damage-related histone H2A.X is mediated by the protein phosphatase eyes absent.
Krishnan N; Jeong DG; Jung SK; Ryu SE; Xiao A; Allis CD; Kim SJ; Tonks NK
J Biol Chem; 2009 Jun; 284(24):16066-16070. PubMed ID: 19351884
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network.
Kingsbury TJ; Kim M; Civin CI
Adv Cancer Res; 2019; 141():1-42. PubMed ID: 30691681
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the threonine-phosphatase of mouse eyes absent 3.
Sano T; Nagata S
FEBS Lett; 2011 Sep; 585(17):2714-9. PubMed ID: 21821028
[TBL] [Abstract][Full Text] [Related]
17. Structural and Functional Analyses of an Allosteric EYA2 Phosphatase Inhibitor That Has On-Target Effects in Human Lung Cancer Cells.
Anantharajan J; Zhou H; Zhang L; Hotz T; Vincent MY; Blevins MA; Jansson AE; Kuan JWL; Ng EY; Yeo YK; Baburajendran N; Lin G; Hung AW; Joy J; Patnaik S; Marugan J; Rudra P; Ghosh D; Hill J; Keller TH; Zhao R; Ford HL; Kang C
Mol Cancer Ther; 2019 Sep; 18(9):1484-1496. PubMed ID: 31285279
[TBL] [Abstract][Full Text] [Related]
18. The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.
Roychoudhury K; Hegde RS
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920226
[TBL] [Abstract][Full Text] [Related]
19. Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.
Krueger AB; Drasin DJ; Lea WA; Patrick AN; Patnaik S; Backos DS; Matheson CJ; Hu X; Barnaeva E; Holliday MJ; Blevins MA; Robin TP; Eisenmesser EZ; Ferrer M; Simeonov A; Southall N; Reigan P; Marugan J; Ford HL; Zhao R
J Biol Chem; 2014 Jun; 289(23):16349-61. PubMed ID: 24755226
[TBL] [Abstract][Full Text] [Related]
20. Identification of transcriptional targets of the dual-function transcription factor/phosphatase eyes absent.
Jemc J; Rebay I
Dev Biol; 2007 Oct; 310(2):416-29. PubMed ID: 17714699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
